IBDEI0SA ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13934,1,4,0)
 ;;=4^Deep Phlebitis-Leg NEC
 ;;^UTILITY(U,$J,358.3,13934,1,5,0)
 ;;=5^451.19
 ;;^UTILITY(U,$J,358.3,13934,2)
 ;;=^269812
 ;;^UTILITY(U,$J,358.3,13935,0)
 ;;=451.81^^85^872^38
 ;;^UTILITY(U,$J,358.3,13935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13935,1,4,0)
 ;;=4^Iliac Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,13935,1,5,0)
 ;;=5^451.81
 ;;^UTILITY(U,$J,358.3,13935,2)
 ;;=^269814
 ;;^UTILITY(U,$J,358.3,13936,0)
 ;;=454.0^^85^872^40
 ;;^UTILITY(U,$J,358.3,13936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13936,1,4,0)
 ;;=4^Leg Varicosity W Ulcer
 ;;^UTILITY(U,$J,358.3,13936,1,5,0)
 ;;=5^454.0
 ;;^UTILITY(U,$J,358.3,13936,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,13937,0)
 ;;=454.1^^85^872^39
 ;;^UTILITY(U,$J,358.3,13937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13937,1,4,0)
 ;;=4^Leg Varicosity W Inflam
 ;;^UTILITY(U,$J,358.3,13937,1,5,0)
 ;;=5^454.1
 ;;^UTILITY(U,$J,358.3,13937,2)
 ;;=^125435
 ;;^UTILITY(U,$J,358.3,13938,0)
 ;;=454.2^^85^872^66
 ;;^UTILITY(U,$J,358.3,13938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13938,1,4,0)
 ;;=4^Varicos Leg Ulcer/Inflam
 ;;^UTILITY(U,$J,358.3,13938,1,5,0)
 ;;=5^454.2
 ;;^UTILITY(U,$J,358.3,13938,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,13939,0)
 ;;=454.9^^85^872^14
 ;;^UTILITY(U,$J,358.3,13939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13939,1,4,0)
 ;;=4^Asymptomatic Varicose Veins
 ;;^UTILITY(U,$J,358.3,13939,1,5,0)
 ;;=5^454.9
 ;;^UTILITY(U,$J,358.3,13939,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,13940,0)
 ;;=459.81^^85^872^68
 ;;^UTILITY(U,$J,358.3,13940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13940,1,4,0)
 ;;=4^Venous Insufficiency NOS
 ;;^UTILITY(U,$J,358.3,13940,1,5,0)
 ;;=5^459.81
 ;;^UTILITY(U,$J,358.3,13940,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,13941,0)
 ;;=457.1^^85^872^43
 ;;^UTILITY(U,$J,358.3,13941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13941,1,4,0)
 ;;=4^Lymphedema,Other
 ;;^UTILITY(U,$J,358.3,13941,1,5,0)
 ;;=5^457.1
 ;;^UTILITY(U,$J,358.3,13941,2)
 ;;=^87693
 ;;^UTILITY(U,$J,358.3,13942,0)
 ;;=593.81^^85^872^53
 ;;^UTILITY(U,$J,358.3,13942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13942,1,4,0)
 ;;=4^Renal Vascular Disorder
 ;;^UTILITY(U,$J,358.3,13942,1,5,0)
 ;;=5^593.81
 ;;^UTILITY(U,$J,358.3,13942,2)
 ;;=^270382
 ;;^UTILITY(U,$J,358.3,13943,0)
 ;;=557.0^^85^872^9
 ;;^UTILITY(U,$J,358.3,13943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13943,1,4,0)
 ;;=4^AC Vasc Insuff Intestine
 ;;^UTILITY(U,$J,358.3,13943,1,5,0)
 ;;=5^557.0
 ;;^UTILITY(U,$J,358.3,13943,2)
 ;;=^2700
 ;;^UTILITY(U,$J,358.3,13944,0)
 ;;=557.1^^85^872^28
 ;;^UTILITY(U,$J,358.3,13944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13944,1,4,0)
 ;;=4^Chr Vasc Insuff Intest
 ;;^UTILITY(U,$J,358.3,13944,1,5,0)
 ;;=5^557.1
 ;;^UTILITY(U,$J,358.3,13944,2)
 ;;=^270251
 ;;^UTILITY(U,$J,358.3,13945,0)
 ;;=557.9^^85^872^67
 ;;^UTILITY(U,$J,358.3,13945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13945,1,4,0)
 ;;=4^Vasc Insuff Intest NOS
 ;;^UTILITY(U,$J,358.3,13945,1,5,0)
 ;;=5^557.9
 ;;^UTILITY(U,$J,358.3,13945,2)
 ;;=^270252
 ;;^UTILITY(U,$J,358.3,13946,0)
 ;;=585.9^^85^872^24
 ;;^UTILITY(U,$J,358.3,13946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13946,1,4,0)
 ;;=4^Chr Kidney Dis NOS
 ;;^UTILITY(U,$J,358.3,13946,1,5,0)
 ;;=5^585.9
 ;;^UTILITY(U,$J,358.3,13946,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,13947,0)
 ;;=682.3^^85^872^21
 ;;^UTILITY(U,$J,358.3,13947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13947,1,4,0)
 ;;=4^Cellulitis Of Arm
 ;;^UTILITY(U,$J,358.3,13947,1,5,0)
 ;;=5^682.3
 ;;^UTILITY(U,$J,358.3,13947,2)
 ;;=^271891
